Top 10 Mid Medical Companies in the US in 2021 by Revenue

OPKO Health Inc, Exact Sciences Corp, Ortho Clinical Diagnostics Holdings Plc, Premier Inc, and Quidel Corp are the top 5 mid-medical companies in the US in 2021 by revenue. Cumulatively, the top 10 mid-medical companies in the US generated revenue of $16,059 million, with average revenue growth of 14.9%, where the highest revenue was generated by OPKO Health Inc ($1,775 million), followed by Exact Sciences Corp ($1,767 million), and Ortho Clinical Diagnostics Holdings Plc ($1,766 million), while the lowest increase was registered by Nuance Communications Inc ($1,284 million). As of FY2021, the highest revenue increase among the top 10 mid-medical companies in the US was posted by Premier Inc (32.4%), followed by OPKO Health Inc (23.6%), while Allscripts Healthcare Solutions Inc registered the lowest revenue growth of 0.02%. They employed a total of 49,352 people in 2021. The United States of America-based OPKO Health Inc is the leading mid-medical company in the US (by revenue). The company reported revenues of $1,775 million for the fiscal year ended December 2021 (FY2021), an increase of 23.6% over FY2020, due to an increase in clinical test reimbursement, clinical test volume, and genomic test volume. The company discovers, develops, manufactures, and commercializes novel diagnostic technologies and pharmaceutical products. As of December 31, 2021, the company operates over 19 subsidiaries in the US, Chile, Mexico, Israel, Spain, Ireland, and Canada. The company employs 5,767 people. Exact Sciences Corp is one of the leading mid-medical companies in the US (by revenue). The company reported revenues of $1,767 million for the fiscal year ended December 2021 (FY2021), an increase of 18.5% over FY2020. The company is a molecular diagnostic company that focuses on the development of tests for various types of cancers. It operates through three product categories: Screening, Precision Oncology, and COVID-19 Testing. It uses a multi-target approach to detect DNA and hemoglobin biomarkers related to colorectal cancer. The company employs 6,420 people.